Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Mono Pharmacare Ltd

NSE: MONOPHARMA · Pharmaceuticals & Biotechnology · 19 announcements

Share price
₹8.40
Market cap
₹14.84 Cr
Revenue (annual)
₹165.7 Cr
Net profit (annual)
₹0.73 Cr
P/E (TTM)
20.3×Sector 47.3×
Promoter holding
56.72%
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

18:38 IST NSE
Annual General Meeting

Mono Pharmacare Annual General Meeting

Mono Pharmacare Limited has fixed September 23, 2026, as the record date for remote e-voting eligibility for its Annual General Meeting.

17:43 IST NSE
Legal & Regulatory

Mono Pharmacare Legal & Regulatory

Mono Pharmacare received NSE fines totaling Rs. 0.02 Crore for non-compliance with SEBI Regulations 33 and 76. The Board has advised strengthening the company's compliance mechanism.

Value
₹0.02 Cr
16:21 IST NSE
Annual General Meeting

Mono Pharmacare Annual General Meeting

Mono Pharmacare Limited has issued a notice for its 4th Annual General Meeting scheduled for September 30, 2026, at its registered office in Ahmedabad.

18:37 IST NSE
Board Meeting Outcome

Mono Pharmacare Board Meeting Outcome

Mono Pharmacare Limited's board meeting approved the re-appointment of a director, the appointment of new statutory auditors, and the scheduling of the company's 4th AGM.

18:53 IST NSE
Board Meeting Date

Mono Pharmacare Board Meeting Date

Mono Pharmacare Limited has scheduled a board meeting for September 3, 2026, to discuss other business matters.

18:36 IST NSE
Other Announcement

Mono Pharmacare Other Announcement

Mono Pharmacare Limited has appointed M/s. B G Kalal & CO as Internal Auditor for FY 2026-27. The board approved this based on Audit Committee recommendations.

Execution
Financial Year 2026-27
16:08 IST NSE
Management Change

Mono Pharmacare Management Change

Mr. Rahul Joshi resigned as Company Secretary and Compliance Officer effective July 1, 2026. The resignation cited pending salary dues and non-payment of salary.

16:00 IST NSE
Board Meeting Outcome

Mono Pharmacare Board Meeting Outcome

Mono Pharmacare approved FY2026 audited financial results and appointed new internal and secretarial auditors. The company also noted the resignation of Company Secretary Rahul Joshi.